scholarly article | Q13442814 |
P50 | author | Nguyen Van Vinh Chau | Q30004276 |
Bridget Wills | Q30112202 | ||
Cameron P. Simmons | Q37392993 | ||
Jeremy Farrar | Q15967402 | ||
P433 | issue | 15 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Dengue virus | Q476209 |
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | 1423-32 | |
P577 | publication date | 2012-04-12 | |
P1433 | published in | The New England Journal of Medicine | Q582728 |
P1476 | title | Dengue | |
P478 | volume | 366 |
Q30250993 | 18F-FDG as an inflammation biomarker for imaging dengue virus infection and treatment response |
Q27926246 | A Cluster-Randomized Controlled Trial to Reduce Diarrheal Disease and Dengue Entomological Risk Factors in Rural Primary Schools in Colombia |
Q36242853 | A Cohort Study of Adult Patients with Severe Dengue in Taiwanese Intensive Care Units: The Elderly and APTT Prolongation Matter for Prognosis. |
Q33422520 | A Dengue Virus Type 4 Model of Disseminated Lethal Infection in AG129 Mice |
Q35577798 | A Prognostic Model for Development of Profound Shock among Children Presenting with Dengue Shock Syndrome |
Q35928781 | A Proteomic Approach Identifies Candidate Early Biomarkers to Predict Severe Dengue in Children |
Q33411427 | A case presentation of a fatal dengue myocarditis showing evidence for dengue virus-induced lesion |
Q56651783 | A comparative analysis of three different methods for the estimation of the basic reproduction number of dengue |
Q66679094 | A cross-sectional study of acute dengue infection in paediatric clinics in Cameroon |
Q63740000 | A cross-sectional survey on the seroprevalence of dengue fever in febrile patients attending health facilities in Cross River State, Nigeria |
Q92320345 | A dengue fever predicting model based on Baidu search index data and climate data in South China |
Q30665268 | A dengue outbreak on a floating village at Cat Ba Island in Vietnam |
Q38394524 | A device architecture for three-dimensional, patterned paper immunoassays. |
Q40135325 | A fatal case of primary dengue infection with myocarditis and cerebral oedema |
Q91685945 | A global model for predicting the arrival of imported dengue infections |
Q41930017 | A lethal model of disseminated dengue virus type 1 infection in AG129 mice |
Q38992578 | A new era of uveitis: impact of polymerase chain reaction in intraocular inflammatory diseases |
Q35022038 | A novel dengue virus inhibitor, BP13944, discovered by high-throughput screening with dengue virus replicon cells selects for resistance in the viral NS2B/NS3 protease |
Q38786420 | A novel dengue virus serotype 1 vaccine candidate based on Japanese encephalitis virus vaccine strain SA14-14-2 as the backbone |
Q35096730 | A novel reporter system for neutralizing and enhancing antibody assay against dengue virus |
Q114704050 | A pan-serotype dengue virus inhibitor targeting the NS3–NS4B interaction |
Q59360698 | A phase 1 study of safety and immunogenicity following intradermal administration of a tetravalent dengue vaccine candidate |
Q40180446 | A plasmid-based reporter system for live cell imaging of dengue virus infected cells |
Q38908540 | A pregnant woman with acute cardiorespiratory failure: dengue myocarditis |
Q94452539 | A prospective 3 year study of clinical spectrum and outcome of dengue fever in ICU from a tertiary care hospital in North India |
Q38658737 | A recombinant, chimeric tetravalent dengue vaccine candidate based on a dengue virus serotype 2 backbone |
Q36607295 | A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trial |
Q35014982 | A systematic review and meta-analysis of dengue risk with temperature change |
Q47111949 | A systematic review of the economic impact of rapid diagnostic tests for dengue |
Q27468820 | Activation of Nrf2 by the dengue virus causes an increase in CLEC5A, which enhances TNF-α production by mononuclear phagocytes |
Q37112881 | Acute renal failure due to rhabdomyolysis following dengue viral infection: a case report |
Q39229727 | Adjuvant PIKA protects hepatoma cells from dengue virus infection by promoting a TBK-1-dependent innate immune response |
Q44840552 | After the FEAST--fluid resuscitation in pediatric sepsis. |
Q25160820 | Alarm Variables for Dengue Outbreaks: A Multi-Centre Study in Asia and Latin America |
Q40040951 | Alpha-mangostin inhibits both dengue virus production and cytokine/chemokine expression |
Q28114617 | An Evidence-Based Algorithm for Early Prognosis of Severe Dengue in the Outpatient Setting |
Q38664968 | An Overview of Animal Models for Arthropod-Borne Viruses |
Q40171566 | An Unusual Case of Osteonecrosis of Jaw associated with Dengue fever and Periodontitis |
Q34353489 | An emerging role for the anti-inflammatory cytokine interleukin-10 in dengue virus infection. |
Q24290781 | An update on the incidence of dengue gaining strength in Saudi Arabia and current control approaches for its vector mosquito |
Q44843450 | Analysing increasing trends of Guillain-Barré Syndrome (GBS) and dengue cases in Hong Kong using meteorological data |
Q26700072 | Anti-flavivirus Activity of Different Tritylated Pyrimidine and Purine Nucleoside Analogues |
Q34550268 | Antibody-dependent enhancement infection facilitates dengue virus-regulated signaling of IL-10 production in monocytes. |
Q36628520 | Antibody-dependent enhancement of dengue virus infection inhibits RLR-mediated Type-I IFN-independent signalling through upregulation of cellular autophagy |
Q52652259 | Antiviral Activity of Novel Quinoline Derivatives against Dengue Virus Serotype 2. |
Q56479686 | Antiviral Effects of Clinically-Relevant Interferon-α and Ribavirin Regimens against Dengue Virus in the Hollow Fiber Infection Model (HFIM) |
Q39370376 | Antiviral activity of Carbenoxolone disodium against dengue virus infection |
Q35085660 | Antiviral macrophage responses in flavivirus encephalitis |
Q40230111 | Apoptotic mediators in patients with severe and non-severe dengue from Brazil |
Q63739951 | Application of a targeted-enrichment methodology for full-genome sequencing of Dengue 1-4, Chikungunya and Zika viruses directly from patient samples |
Q52647635 | Applications of gold nanoparticles in virus detection. |
Q26859651 | Approaches to refining estimates of global burden and economics of dengue |
Q56797874 | Arbovirus Surveillance near the Mexico-U.S. Border: Isolation and Sequence Analysis of Chikungunya Virus from Patients with Dengue-like Symptoms in Reynosa, Tamaulipas |
Q57008751 | Arboviruses and pregnancy: maternal, fetal, and neonatal effects |
Q56797968 | Ask the Experts: Surveillance of global dengue distribution |
Q37533789 | Assembly of the genome of the disease vector Aedes aegypti onto a genetic linkage map allows mapping of genes affecting disease transmission |
Q92936610 | Assessing dengue control in Tokyo, 2014 |
Q34550185 | Assessing positivity and circulating levels of NS1 in samples from a 2012 dengue outbreak in Rio de Janeiro, Brazil |
Q37152700 | Assessing socioeconomic vulnerability to dengue fever in Cali, Colombia: statistical vs expert-based modeling |
Q34479588 | Assessing the epidemiological effect of wolbachia for dengue control |
Q30862635 | Assessing the methods needed for improved dengue mapping: a SWOT analysis |
Q28656188 | Assessing the relationship between vector indices and dengue transmission: a systematic review of the evidence |
Q51149102 | Assessment of Aedes albopictus reference genes for quantitative PCR at different stages of development. |
Q33723518 | Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-naïve adults in Mexico |
Q60956543 | Assessment of metagenomic Nanopore and Illumina sequencing for recovering whole genome sequences of chikungunya and dengue viruses directly from clinical samples |
Q40167189 | Association Between Increased Vascular Nitric Oxide Bioavailability and Progression to Dengue Hemorrhagic Fever in Adults |
Q37597445 | Association DENV1 and DENV2 infection with high serum levels of soluble thrombomodulin and VEGF in patients with dengue fever and dengue hemorrhagic fever |
Q36487320 | Association between magnitude of the virus-specific plasmablast response and disease severity in dengue patients |
Q27468948 | Association of BAK1 single nucleotide polymorphism with a risk for dengue hemorrhagic fever |
Q37161920 | Association of Microvascular Function and Endothelial Biomarkers With Clinical Outcome in Dengue: An Observational Study |
Q98174618 | Association of genotype III of dengue virus serotype 3 with disease outbreak in Eastern Sudan, 2019 |
Q92845746 | Asymptomatic Dengue Virus Infections, Cambodia, 2012-2013 |
Q34352267 | Autophagy facilitates antibody-enhanced dengue virus infection in human pre-basophil/mast cells. |
Q58701074 | B cell subset alteration and the expression of tissue homing molecules in dengue infected patients |
Q40094919 | B cells naturally induced during dengue virus infection release soluble CD27, the plasma level of which is associated with severe forms of pediatric dengue |
Q38905651 | Bacterial coinfections in dengue virus disease: what we know and what is still obscure about an emerging concern. |
Q21562283 | Big data opportunities for global infectious disease surveillance |
Q40040211 | Biodistribution and safety of a live attenuated tetravalent dengue vaccine in the cynomolgus monkey |
Q24570070 | Bioinformatic analysis reveals the expression of unique transcriptomic signatures in Zika virus infected human neural stem cells |
Q40251552 | Breast milk as a possible route of vertical transmission of dengue virus? |
Q89733973 | C-reactive protein as a potential biomarker for disease progression in dengue: a multi-country observational study |
Q35760439 | CD8+ T Cells Can Mediate Short-Term Protection against Heterotypic Dengue Virus Reinfection in Mice |
Q39085489 | CYD-TDV dengue vaccine: systematic review and meta-analysis of efficacy, immunogenicity and safety |
Q30361134 | Cardiovascular manifestations of the emerging dengue pandemic. |
Q40241605 | Cellulose-based diagnostic devices for diagnosing serotype-2 dengue fever in human serum |
Q97521483 | Challenges in Dengue Vaccines Development: Pre-existing Infections and Cross-Reactivity |
Q52692686 | Characteristics and predictors for gastrointestinal hemorrhage among adult patients with dengue virus infection: Emphasizing the impact of existing comorbid disease(s). |
Q47558465 | Characterization of a candidate tetravalent vaccine based on 2'-O-methyltransferase mutants |
Q52646073 | Characterization of a murine model of non-lethal, symptomatic dengue virus infection. |
Q66678846 | Characterization of clinical patterns of dengue patients using an unsupervised machine learning approach |
Q36255068 | Characterization of lethal dengue virus type 4 (DENV-4) TVP-376 infection in mice lacking both IFN-α/β and IFN-γ receptors (AG129) and comparison with the DENV-2 AG129 mouse model |
Q37327964 | Characterization of the Myocarditis during the worst outbreak of dengue infection in China |
Q38260350 | Chlorophyll derivatives can be an efficient weapon in the fight against dengue |
Q41928393 | Chymase is a Predictive Biomarker of Dengue Hemorrhagic Fever in Pediatric and Adult Patients |
Q57100423 | Circulating dengue virus serotypes in Bangladesh from 2013 to 2016 |
Q27468814 | Circulating serotypes of dengue virus and their incursion into non-endemic areas of Pakistan; a serious threat |
Q30893969 | Climate change and vector-borne diseases: what are the implications for public health research and policy? |
Q93046783 | Climate change impact on migration, travel, travel destinations and the tourism industry |
Q57148624 | Clinical Features and Laboratory Findings of Travelers Returning to South Australia with Dengue Virus Infection |
Q33629506 | Clinical Utility of the Nonstructural 1 Antigen Rapid Diagnostic Test in the Management of Dengue in Returning Travelers With Fever |
Q50532065 | Clinical and Hematological Profile of Patients with Dengue Fever at a Tertiary Care Hospital - An Observational Study. |
Q33432889 | Clinical and histopathological features of fatal cases with dengue and chikungunya virus co-infection in Colombia, 2014 to 2015. |
Q33757489 | Clinical and virological characteristics of dengue in Surabaya, Indonesia |
Q40039687 | Clinical application of modified bag-of-features coupled with hybrid neural-based classifier in dengue fever classification using gene expression data |
Q37272298 | Clinical characteristics of Dengue shock syndrome in Vietnamese children: a 10-year prospective study in a single hospital |
Q35954329 | Clinical evaluation of dengue and identification of risk factors for severe disease: protocol for a multicentre study in 8 countries |
Q35140633 | Clinical features of and risk factors for rhabdomyolysis among adult patients with dengue virus infection |
Q33841065 | Clinical presentation of dengue by serotype and year of epidemic in Martinique |
Q92860618 | Clinical prognostic models for severe dengue: a systematic review protocol |
Q24701811 | Co-distribution and co-infection of chikungunya and dengue viruses |
Q99634058 | Co-infection of SARS-CoV-2 and dengue virus: a clinical challenge |
Q37734037 | Comments on the clinical and laboratory characteristics of patients with dengue hemorrhagic fever manifestations and their transfusion profile |
Q36078741 | Comparative Susceptibility of Aedes albopictus and Aedes aegypti to Dengue Virus Infection After Feeding on Blood of Viremic Humans: Implications for Public Health |
Q34143958 | Comparative assessment of the bacterial communities associated with Aedes aegypti larvae and water from domestic water storage containers. |
Q99411828 | Comparison of dengue case classification schemes and evaluation of biological changes in different dengue clinical patterns in a longitudinal follow-up of hospitalized children in Cambodia |
Q56748346 | Complementary and alternative medicine in alliance with conventional medicine for dengue therapeutics and prevention |
Q35758626 | Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies |
Q64101350 | Concurrent infections of dengue virus serotypes in Bali, Indonesia |
Q34500917 | Considerations in the design of clinical trials to test novel entomological approaches to dengue control |
Q91807708 | Considering Genomic and Immunological Correlates of Protection for a Dengue Intervention |
Q43046807 | Construction and Identification of Recombinant HEK293T Cell Lines Expressing Non-structural Protein 1 of Zika Virus |
Q40198029 | Construction and preliminary investigation of a novel dengue serotype 4 chimeric virus using Japanese encephalitis vaccine strain SA14-14-2 as the backbone |
Q37619957 | Consumer Willingness to Pay for Dengue Vaccine (CYD-TDV, Dengvaxia®) in Brazil; Implications for Future Pricing Considerations |
Q28550365 | Copulation Activity, Sperm Production and Conidia Transfer in Aedes aegypti Males Contaminated by Metarhizium anisopliae: A Biological Control Prospect |
Q89868562 | Coronary Artery Spasms Mimicking Acute ST-Elevation Myocardial Infarction in Dengue Haemorrhagic Fever |
Q34779065 | Correlation between dengue-specific neutralizing antibodies and serum avidity in primary and secondary dengue virus 3 natural infections in humans |
Q35590817 | Correlation between serum levels of anti-endothelial cell autoantigen and anti-dengue virus nonstructural protein 1 antibodies in dengue patients |
Q22918883 | Corticosteroids for dengue infection |
Q36404706 | Cost implications of implementation of pathogen-inactivated platelets |
Q47578242 | Cost-effectiveness of dengue vaccination in ten endemic countries |
Q30250932 | Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope |
Q47196084 | Critical low temperature for the survival of Aedes aegypti in Taiwan |
Q34354665 | Cross-reactivities between human IgMs and the four serotypes of dengue virus as probed with artificial homodimers of domain-III from the envelope proteins |
Q38661075 | Current issues in the economics of vaccination against dengue |
Q38992396 | Current management of severe dengue infection |
Q33408300 | Current progress in dengue vaccines |
Q38157397 | DNA-immunisation with dengue virus E protein domains I/II, but not domain III, enhances Zika, West Nile and Yellow Fever virus infection. |
Q38740182 | Delayed care-seeking and outcome of dengue-infected patients |
Q91271250 | Dengue |
Q26314480 | Dengue Deaths: Associated Factors and Length of Hospital Stay |
Q27304342 | Dengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral Serotypes |
Q33423535 | Dengue Hemorrhagic Fever in a Japanese Traveler with Pre-existing Japanese Encephalitis Virus Antibody |
Q39371396 | Dengue Hemorrhagic Fever: A State-of-the-Art Review Focused in Pulmonary Involvement |
Q40133947 | Dengue Human Infection Models to Advance Dengue Vaccine Development |
Q59359154 | Dengue Infection Spectrum in Guangzhou: A Cross-Sectional Seroepidemiology Study among Community Residents between 2013 and 2015 |
Q28087420 | Dengue Virus Control of Type I IFN Responses: A History of Manipulation and Control |
Q38963303 | Dengue Virus Exposures Among Deployed U.S. Military Personnel |
Q27316360 | Dengue Virus Impairs Mitochondrial Fusion by Cleaving Mitofusins |
Q35833914 | Dengue Virus Infection Causes the Activation of Distinct NF-κB Pathways for Inducible Nitric Oxide Synthase and TNF-α Expression in RAW264.7 Cells |
Q35641205 | Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice. |
Q36280060 | Dengue Virus-Induced Inflammation of the Endothelium and the Potential Roles of Sphingosine Kinase-1 and MicroRNAs. |
Q65000498 | Dengue and Zika Virus Diagnostic Testing for Patients with a Clinically Compatible Illness and Risk for Infection with Both Viruses. |
Q99574588 | Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models |
Q35050760 | Dengue and its effects on liver |
Q50793626 | Dengue as a cause of fever during pregnancy: a report of two cases. |
Q97525857 | Dengue awareness and its determinants among urban adults of Rohtak, Haryana |
Q35598958 | Dengue disease outbreak definitions are implicitly variable |
Q35574035 | Dengue epidemiology in selected endemic countries: factors influencing expansion factors as estimates of underreporting. |
Q34320466 | Dengue expansion in Africa-not recognized or not happening? |
Q49940527 | Dengue fever : Symptoms, epidemiology, entomology, pathogen diagnosis and prevention |
Q33427475 | Dengue fever as a cause of hemophagocytic lymphohistiocytosis |
Q39146003 | Dengue fever complicated by hemophagocytosis. |
Q30245613 | Dengue fever virus in Pakistan: effects of seasonal pattern and temperature change on distribution of vector and virus |
Q41930015 | Dengue fever. Clinical features of 567 consecutive patients admitted to a tertiary care center in Saudi Arabia. |
Q28651505 | Dengue fever: a Wikipedia clinical review |
Q39590469 | Dengue human infection models supporting drug development |
Q38386336 | Dengue human infection models to advance dengue vaccine development |
Q35692481 | Dengue in adults admitted to a referral hospital in Hanoi, Vietnam |
Q36433186 | Dengue in the context of "safe blood" and global epidemiology: to screen or not to screen? |
Q34766802 | Dengue in travelers: kinetics of viremia and NS1 antigenemia and their associations with clinical parameters |
Q40056062 | Dengue infection during pregnancy and risk of preterm birth |
Q42996339 | Dengue infection. |
Q35458940 | Dengue on islands: a Bayesian approach to understanding the global ecology of dengue viruses |
Q55046089 | Dengue seroprevalence: data from the clinical development of a tetravalent dengue vaccine in 14 countries (2005-2014). |
Q34042859 | Dengue serotype cross-reactive, anti-e protein antibodies confound specific immune memory for 1 year after infection |
Q37270826 | Dengue serotype immune-interactions and their consequences for vaccine impact predictions |
Q33406567 | Dengue surveillance in Veterans Affairs healthcare facilities, 2007-2010 |
Q28542607 | Dengue therapeutics, chemoprophylaxis, and allied tools: state of the art and future directions |
Q38732727 | Dengue virus induces mitochondrial elongation through impairment of Drp1-triggered mitochondrial fission |
Q90197644 | Dengue virus infection in people residing in Africa: a systematic review and meta-analysis of prevalence studies |
Q33976500 | Dengue virus infection induces expansion of a CD14(+)CD16(+) monocyte population that stimulates plasmablast differentiation |
Q39606954 | Dengue virus infection induces formation of G3BP1 granules in human lung epithelial cells |
Q47555963 | Dengue virus infection-enhancement activity in neutralizing antibodies of healthy adults before dengue season as determined by using FcγR-expressing cells |
Q39500287 | Dengue virus persists and replicates during storage of platelet and red blood cell units. |
Q37694855 | Dengue virus photo-inactivated in presence of 1,5-iodonaphthylazide (INA) or AMT, a psoralen compound (4'-aminomethyl-trioxsalen) is highly immunogenic in mice |
Q36267622 | Dengue virus serotype 2 infection alters midgut and carcass gene expression in the Asian tiger mosquito, Aedes albopictus. |
Q56476041 | Dengue virus serotype distribution based on serological evidence in pediatric urban population in Indonesia |
Q34718200 | Dengue virus type 3 adaptive changes during epidemics in São Jose de Rio Preto, Brazil, 2006-2007. |
Q26751422 | Dengue virus: A global human threat: Review of literature |
Q27927998 | Dengue with a morbilliform rash and a positive tourniquet test |
Q62485221 | Dengue, chikungunya and zika virus coinfection: results of the national surveillance during the zika epidemic in Colombia |
Q91589943 | Dengue, chikungunya, and scrub typhus are important etiologies of non-malarial febrile illness in Rourkela, Odisha, India |
Q40215531 | Dengue: "plus ça change, plus c'est la même chose". |
Q27010609 | Dengue: Moving from Current Standard of Care to State-of-the-Art Treatment |
Q47103344 | Dengue: The break-bone fever outbreak in Kerala, India |
Q59352698 | Dengue: a growing threat requiring vaccine development for disease prevention |
Q39597018 | Dengue: update on epidemiology |
Q27468688 | DengueME: A Tool for the Modeling and Simulation of Dengue Spatiotemporal Dynamics |
Q96221013 | DenvInD: dengue virus inhibitors database for clinical and molecular research |
Q36689564 | Detection of DENV-4 genotype I from mosquitoes collected in the city of Manaus, Brazil |
Q35760466 | Determinants of Dengue Virus NS4A Protein Oligomerization |
Q36669080 | Determination of viremia and concentration of circulating nonstructural protein 1 in patients infected with dengue virus in Mexico |
Q35058916 | Developing a social autopsy tool for dengue mortality: a pilot study |
Q64125827 | Development of Dengue-type NS1 ELISA for Rapid Detection and Differentiation of Dengue Serotypes during Early Infection |
Q36862355 | Development of a Simple Clinical Risk Score for Early Prediction of Severe Dengue in Adult Patients |
Q57030919 | Development of standard clinical endpoints for use in dengue interventional trials |
Q28357303 | Diabetes, cardiac disorders and asthma as risk factors for severe organ involvement among adult dengue patients: A matched case-control study |
Q35124863 | Diagnosing dengue at the point-of-care: utility of a rapid combined diagnostic kit in Singapore |
Q35910821 | Diagnostic accuracy of peripheral venous lactate and the 2009 WHO warning signs for identifying severe dengue in Thai adults: a prospective observational study |
Q36639140 | Diarrhea and dengue control in rural primary schools in Colombia: study protocol for a randomized controlled trial |
Q58778953 | Differences in clinical features and dengue severity between local and migrant Chinese with dengue infection in Singapore |
Q57064402 | Different aspects of platelet evaluation in dengue: measurement of circulating mediators, ability to interact with the virus, the degree of activation and quantification of intraplatelet protein content |
Q35130239 | Differential susceptibility of two field aedes aegypti populations to a low infectious dose of dengue virus |
Q53409127 | Direct Growth of Bacteria in Headspace Vials Allows for Screening of Volatiles by Gas Chromatography Mass Spectrometry. |
Q34408025 | Direct and indirect interactions in the recognition between a cross-neutralizing antibody and the four serotypes of dengue virus |
Q36048467 | Discovery and Validation of Prognostic Biomarker Models to Guide Triage among Adult Dengue Patients at Early Infection |
Q91973559 | Discovery of Ganoderma lucidum triterpenoids as potential inhibitors against Dengue virus NS2B-NS3 protease |
Q33567787 | Disease Burden of Dengue in the Philippines: Adjusting for Underreporting by Comparing Active and Passive Dengue Surveillance in Punta Princesa, Cebu City |
Q30236000 | Disease and economic burdens of dengue |
Q35837142 | Dispersal of Engineered Male Aedes aegypti Mosquitoes |
Q33728716 | Dissecting the human serum antibody response to secondary dengue virus infections |
Q56000986 | Distinguishing Zika and Dengue Viruses through Simple Clinical Assessment, Singapore |
Q52671501 | Divergent Role of Sphingosine 1-Phosphate in Liver Health and Disease. |
Q28119735 | Diversity of Cultivable Midgut Microbiota at Different Stages of the Asian Tiger Mosquito, Aedes albopictus from Tezpur, India |
Q37089546 | Dogma in classifying dengue disease |
Q35107319 | Dynamic spatiotemporal trends of dengue transmission in the Asia-Pacific region, 1955-2004. |
Q57583841 | Economic Valuation of the Threat Posed by the Establishment of the Asian Tiger Mosquito in Australia |
Q35192267 | Economic and disease burden of dengue in Mexico |
Q21092274 | Economic and disease burden of dengue in Southeast Asia |
Q61798363 | Economic burden of dengue in Indonesia |
Q92054238 | Economic impact of dengue fever in Latin America and the Caribbean: a systematic review |
Q56669647 | Effective surveillance systems for vector-borne diseases in urban settings and translation of the data into action: a scoping review |
Q30250906 | Effects of local and regional climatic fluctuations on dengue outbreaks in southern Taiwan |
Q34422058 | Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial |
Q52602680 | Efficacy of Aedes aegypti control by indoor Ultra Low Volume (ULV) insecticide spraying in Iquitos, Peru. |
Q90516574 | Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trial |
Q92648804 | Emerging and threatening vector-borne zoonoses in the world and in Europe: a brief update |
Q63246190 | Endogenous non-retroviral elements in genomes of Aedes mosquitoes and vector competence |
Q39609743 | Endothelial nitric oxide pathways in the pathophysiology of dengue: a prospective observational study |
Q57040576 | Endothelins in inflammatory neurological diseases |
Q36160341 | Enhanced Surveillance for Fatal Dengue-Like Acute Febrile Illness in Puerto Rico, 2010-2012. |
Q33411935 | Enhanced arbovirus surveillance with deep sequencing: Identification of novel rhabdoviruses and bunyaviruses in Australian mosquitoes |
Q36363996 | Enhanced performance of an innovative dengue IgG/IgM rapid diagnostic test using an anti-dengue EDI monoclonal antibody and dengue virus antigen |
Q29196526 | Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity |
Q48508987 | Entomopathogenic fungi and their potential for the management of Aedes aegypti (Diptera: Culicidae) in the Americas |
Q26314700 | Epidemic resurgence of dengue fever in Singapore in 2013-2014: A virological and entomological perspective |
Q51784584 | Epidemiological Characteristics and Space-Time Analysis of the 2015 Dengue Outbreak in the Metropolitan Region of Tainan City, Taiwan. |
Q92492554 | Epidemiological and Evolutionary Analysis of Dengue-1 Virus Detected in Guangdong during 2014: Recycling of Old and Formation of New Lineages |
Q64064740 | Epidemiological and clinical characteristics of Dengue virus outbreaks in two regions of China, 2014 - 2015 |
Q90578267 | Epidemiological and clinical features of laboratory-diagnosed severe fever with thrombocytopenia syndrome in China, 2011-17: a prospective observational study |
Q47095800 | Epidemiological characteristics of dengue disease in Saurashtra region, India, during year 2015. |
Q47192433 | Epidemiological, Serological, and Virological Features of Dengue in Nha Trang City, Vietnam |
Q39530072 | Epidemiology and Disease Burden of Pediatric Dengue in Venezuela |
Q39557229 | Essential oils with insecticidal activity against larvae of Aedes aegypti (Diptera: Culicidae). |
Q34766904 | Estimates of dengue force of infection in children in Colombo, Sri Lanka |
Q31113799 | Estimating Dengue Transmission Intensity from Case-Notification Data from Multiple Countries |
Q64962715 | Estimating Past, Present, and Future Trends in the Global Distribution and Abundance of the Arbovirus Vector Aedes aegypti Under Climate Change Scenarios. |
Q35448628 | Estimating dengue transmission intensity from sero-prevalence surveys in multiple countries. |
Q50299354 | Evaluation of Macaca radiata as a non-human primate model of Dengue virus infection |
Q37125047 | Evaluation of a new commercially available immunoglobulin M capture enzyme-linked immunosorbent assay for diagnosis of dengue virus infection |
Q40243832 | Evaluation of cardiac involvement during dengue viral infection |
Q34448752 | Evaluation of dengue NS1 antigen rapid tests and ELISA kits using clinical samples |
Q39403339 | Evaluation of tetravalent and conserved synthetic peptides vaccines derived from Dengue virus Envelope domain I and II. |
Q37734091 | Evaluation of the WHO classification of dengue disease severity during an epidemic in 2011 in the state of Ceará, Brazil |
Q40126576 | Evaluation of the World Health Organization 2009 classification of dengue severity in autopsied individuals, during the epidemics of 2011 and 2012 in Brazil |
Q35751710 | Evaluation of the diagnostic accuracy of nonstructural protein 1 Ag-based tests for dengue virus in Asian population: a meta-analysis |
Q26315207 | Evaluation of the vector competence of a native UK mosquito Ochlerotatus detritus (Aedes detritus) for dengue, chikungunya and West Nile viruses |
Q38742066 | Evasion of early innate immune response by 2'-O-methylation of dengue genomic RNA. |
Q24289635 | Expanded Spectrum of Congenital Ocular Findings in Microcephaly with Presumed Zika Infection |
Q34640293 | Experimental inoculation of Artibeus jamaicensis bats with dengue virus serotypes 1 or 4 showed no evidence of sustained replication. |
Q36586306 | Experimental therapies for yellow fever |
Q90748722 | Exploring Epidemiological Characteristics of Domestic Imported Dengue Fever in Mainland China, 2014-2018 |
Q41919588 | Exploring the Immunopathogenesis of Viral Hemorrhagic Fever in Mice with a Humanized Immune System |
Q38905583 | Exploring the possibility of arthropod transmission of HCV. |
Q30423742 | Extensive structural change of the envelope protein of dengue virus induced by a tuned ionic strength: conformational and energetic analyses. |
Q45434695 | Fascinating interaction between host and pathogen |
Q33415622 | Fatal outcome of infection by dengue 4 in a patient with thrombocytopenic purpura as a comorbid condition in Brazil |
Q38615396 | Fc receptors in antibody-dependent enhancement of viral infections |
Q40215258 | Field validation of the gravid Aedes trap (GAT) for collection of Aedes aegypti (Diptera: Culicidae). |
Q60913859 | Fine-scale spatial and temporal dynamics of kdr haplotypes in Aedes aegypti from Mexico |
Q31156754 | First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodies |
Q55452101 | First report on the application of near-infrared spectroscopy to predict the age of Aedes albopictus Skuse. |
Q38964006 | Flavivirus RNA transactions from viral entry to genome replication |
Q90798978 | Flavivirus infection-A review of immunopathogenesis, immunological response, and immunodiagnosis |
Q30857727 | Flaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus |
Q90669557 | Future risk of dengue fever to workforce and industry through global supply chain |
Q37432401 | Galectin-9 plasma levels reflect adverse hematological and immunological features in acute dengue virus infection. |
Q34917119 | Genetic mapping of specific interactions between Aedes aegypti mosquitoes and dengue viruses |
Q92416661 | Genetic risk for dengue hemorrhagic fever and dengue fever in multiple ancestries |
Q34639559 | Genetic variants of MICB and PLCE1 and associations with non-severe dengue |
Q33785152 | Genetic variants of MICB and PLCE1 and associations with the laboratory features of dengue |
Q28073351 | Genomic approaches for understanding dengue: insights from the virus, vector, and host |
Q39078484 | Genomics, proteomics and evolution of dengue virus |
Q40046100 | Global Epidemiology of Dengue Outbreaks in 1990-2015: A Systematic Review and Meta-Analysis |
Q64075555 | Global warming and arboviral infections |
Q90099025 | Glycyrrhizic acid derivatives as Dengue virus inhibitors |
Q92802144 | Heatwaves and dengue outbreaks in Hanoi, Vietnam: New evidence on early warning |
Q40198146 | High dengue NS1 antigenemia in febrile patients in Ibadan, Nigeria |
Q27928048 | High frequency of pre-existing neutralizing antibody responses in patients with dengue during an outbreak in Central Brazil |
Q90129869 | High levels of serum hyaluronan is an early predictor of dengue warning signs and perturbs vascular integrity |
Q36669119 | High mobility group box 1 protein as an auxiliary biomarker for dengue diagnosis |
Q89467154 | High prevalence of Phasi Charoen-like virus from wild-caught Aedes aegypti in Grenada, W.I. as revealed by metagenomic analysis |
Q93140606 | Hijacking the Host Immune Cells by Dengue Virus: Molecular Interplay of Receptors and Dengue Virus Envelope |
Q36895627 | Host and viral features of human dengue cases shape the population of infected and infectious Aedes aegypti mosquitoes |
Q36545428 | House-to-house human movement drives dengue virus transmission |
Q42370266 | Household costs of hospitalized dengue illness in semi-rural Thailand |
Q41921547 | How does competition among wild type mosquitoes influences the performance of Aedes aegypti and dissemination of Wolbachia pipientis? |
Q36322128 | Human Subtilisin Kexin Isozyme-1 (SKI-1)/Site-1 Protease (S1P) regulates cytoplasmic lipid droplet abundance: A potential target for indirect-acting anti-dengue virus agents |
Q27468843 | Human heme oxygenase 1 is a potential host cell factor against dengue virus replication |
Q39143936 | IFITM3-containing exosome as a novel mediator for anti-viral response in dengue virus infection |
Q35807844 | Identification of clinical factors associated with severe dengue among Thai adults: a prospective study |
Q40058742 | Identification of new potent inhibitors of dengue virus NS3 protease from traditional Chinese medicine database |
Q43046909 | Identification of novel antiviral of fungus-derived brefeldin A against dengue viruses |
Q37372595 | Immunogenicity and safety of a recombinant tetravalent dengue vaccine in children and adolescents ages 9-16 years in Brazil |
Q47584703 | Immunogenicity and safety of one versus two doses of tetravalent dengue vaccine in healthy children aged 2-17 years in Asia and Latin America: 18-month interim data from a phase 2, randomised, placebo-controlled study. |
Q39410861 | Immunopathogenesis Versus Protection in Dengue Virus Infections |
Q30151102 | Impact of human mobility on the emergence of dengue epidemics in Pakistan |
Q92239353 | Impaired production of immune mediators in dengue virus type 2-infected mononuclear cells of adults with end stage renal disease |
Q45349238 | Implications of a possible route of vertical transmission of dengue virus by breast milk |
Q30811442 | Important vector-borne infectious diseases among humans in Germany. Epidemiological aspects |
Q92002145 | Importation of dengue, Zika and chikungunya infections in Europe: the current situation in Greece |
Q30250977 | In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination |
Q60921167 | Incidence and Outcome of Severe and Nonsevere Thrombocytopenia Associated With Zika Virus Infection-Puerto Rico, 2016 |
Q92638319 | Incidence dynamics and investigation of key interventions in a dengue outbreak in Ningbo City, China |
Q56880391 | Increased Adult Aedes aegypti and Culex quinquefasciatus (Diptera: Culicidae) Abundance in a Dengue Transmission Hotspot, Compared to a Coldspot, within Kaohsiung City, Taiwan |
Q37743291 | Increased Serum Hyaluronic Acid and Heparan Sulfate in Dengue Fever: Association with Plasma Leakage and Disease Severity |
Q40233196 | Increased production of interleukin-4, interleukin-10, and granulocyte-macrophage colony-stimulating factor by type 2 diabetes' mononuclear cells infected with dengue virus, but not increased intracellular viral multiplication. |
Q36305179 | Increased sensitivity of NS1 ELISA by heat dissociation in acute dengue 4 cases. |
Q56428059 | Inferences about spatiotemporal variation in dengue virus transmission are sensitive to assumptions about human mobility: a case study using geolocated tweets from Lahore, Pakistan |
Q91962220 | Insight into the Tropism of Dengue Virus in Humans |
Q92419130 | Inter-outbreak stability reflects the size of the susceptible pool and forecasts magnitudes of seasonal epidemics |
Q34633606 | International dispersal of dengue through air travel: importation risk for Europe |
Q27334417 | Intra-epidemic evolutionary dynamics of a Dengue virus type 1 population reveal mutant spectra that correlate with disease transmission |
Q91605068 | Intra-host growth kinetics of dengue virus in the mosquito Aedes aegypti |
Q36251262 | Intracranial Injection of Dengue Virus Induces Interferon Stimulated Genes and CD8+ T Cell Infiltration by Sphingosine Kinase 1 Independent Pathways |
Q28656119 | Investigation of the First Case of Dengue Virus Infection Acquired in Western Australia in Seven Decades: Evidence of Importation of Infected Mosquitoes? |
Q38870485 | Investigational drugs in early development for treating dengue infection. |
Q24288742 | Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis |
Q40162717 | Is excessive acetaminophen intake associated with transaminitis in adult patients with dengue fever? |
Q92728260 | Isolation and characterization of exosomes released from mosquito cells infected with dengue virus |
Q35998523 | Knowledge, attitudes, and practices of Florida physicians regarding dengue before and after an educational intervention |
Q37599853 | LILR-B1 blocks activating FcγR signaling to allow antibody dependent enhancement of dengue virus infection |
Q27349518 | Laser induced mortality of Anopheles stephensi mosquitoes |
Q39633694 | Lead optimization of spiropyrazolopyridones: a new and potent class of dengue virus inhibitors |
Q36615111 | Lessons from malaria control to help meet the rising challenge of dengue |
Q37599913 | Leukocyte immunoglobulin-like receptor B1 is critical for antibody-dependent dengue |
Q33916139 | Long-term and seasonal dynamics of dengue in Iquitos, Peru |
Q37706823 | Long-term safety assessment of live attenuated tetravalent dengue vaccines: deliberations from a WHO technical consultation |
Q40218605 | Loss of appetite and strength in the geriatric population: diagnostic symptoms for dengue |
Q38056781 | Lovastatin for adult patients with dengue: protocol for a randomised controlled trial |
Q36497872 | Lovastatin for the Treatment of Adult Patients With Dengue: A Randomized, Double-Blind, Placebo-Controlled Trial |
Q39001736 | Low sensitivity of NS1 protein tests evidenced during a dengue type 2 virus outbreak in Santos, Brazil, in 2010. |
Q33439479 | Management dilemmas in a rare case of pituitary apoplexy in the setting of dengue hemorrhagic fever |
Q55514508 | Mapping dengue risk in Singapore using Random Forest. |
Q28114614 | Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to DENV4 Infection and Vaccination |
Q60924527 | Mapping the global potential distributions of two arboviral vectors Aedes aegypti and Ae. albopictus under changing climate |
Q40152339 | Mast cell-macrophage dynamics in modulation of dengue virus infection in skin |
Q33430984 | Maternal Antibody-Mediated Disease Enhancement in Type I Interferon-Deficient Mice Leads to Lethal Disease Associated with Liver Damage |
Q50151207 | Measles-derived vaccines to prevent emerging viral diseases |
Q91904637 | Metabolic perturbations and cellular stress underpin susceptibility to symptomatic live-attenuated yellow fever infection |
Q35935426 | Metabolomics-Based Discovery of Small Molecule Biomarkers in Serum Associated with Dengue Virus Infections and Disease Outcomes |
Q49789764 | Metformin Use and Severe Dengue in Diabetic Adults. |
Q40242070 | Micro-spot with integrated pillars (MSIP) for detection of dengue virus NS1. |
Q99578541 | Migration rate estimation in an epidemic network |
Q37443189 | Mitigating the Risk of Transfusion-Transmitted Dengue in Australia |
Q66679472 | Model-based assessment of public health impact and cost-effectiveness of dengue vaccination following screening for prior exposure |
Q35326145 | Modeling the impact on virus transmission of Wolbachia-mediated blocking of dengue virus infection of Aedes aegypti |
Q100503905 | Modeling the potential of wAu-Wolbachia strain invasion in mosquitoes to control Aedes-borne arboviral infections |
Q98943898 | Modeling the relative role of human mobility, land-use and climate factors on dengue outbreak emergence in Sri Lanka |
Q27468650 | Molecular Characterization and Viral Origin of the 2015 Dengue Outbreak in Xishuangbanna, Yunnan, China |
Q60300856 | Molecular detection of dengue virus in patients suspected of Ebola virus disease in Ghana |
Q27787393 | Molecular surveillance of dengue in Minas Gerais provides insights on dengue virus 1 and 4 circulation in Brazil |
Q34952289 | Molecular surveillance of dengue in Semarang, Indonesia revealed the circulation of an old genotype of dengue virus serotype-1. |
Q88532432 | Monoclonal antibodies as anti-infective products: a promising future? |
Q38059522 | Mosquito ecology and control of malaria |
Q28078140 | Mosquito-transmitted viruses - the great Brazilian challenge |
Q24276139 | Mouse models of dengue virus infection for vaccine testing |
Q58566114 | Multiplexed FluoroSpot for the Analysis of Dengue Virus- and Zika Virus-Specific and Cross-Reactive Memory B Cells |
Q40062309 | Mutagenesis of Dengue Virus Protein NS2A Revealed a Novel Domain Responsible for Virus-Induced Cytopathic Effect and Interactions between NS2A and NS2B Transmembrane Segments |
Q90277206 | Myocarditis Following Recent Chikungunya and Dengue Virus Coinfection: A Case Report |
Q24194181 | NS1 antigen detecting assays for diagnosing acute dengue infection in people living in or returning from endemic countries |
Q40222284 | NS1 antigen testing for the diagnosis of dengue in returned Israeli travelers |
Q38221220 | Natural products as source of potential dengue antivirals |
Q27680452 | Near-Atomic Resolution Cryo-Electron Microscopic Structure of Dengue Serotype 4 Virus |
Q41919556 | Neurological Complications in a Polynesian Traveler with Dengue |
Q54319582 | Neurological Manifestations of Dengue Infection. |
Q28296618 | Neurological complications of dengue virus infection |
Q39512343 | Neurological manifestations of dengue in Central Brazil |
Q28075970 | Neutrophil Extracellular Traps Go Viral |
Q38093249 | New development in the diagnosis of dengue infections |
Q27014786 | New generation humanized mice for virus research: comparative aspects and future prospects |
Q38646923 | New insights into the immunopathology and control of dengue virus infection |
Q33425587 | New parameters available on Sysmex XE-5000 hematology analyzers contribute to differentiating dengue from leptospirosis and enteric fever |
Q36797668 | No evidence for local adaptation of dengue viruses to mosquito vector populations in Thailand |
Q38605200 | Nucleic acid (DNA) immunization as a platform for dengue vaccine development |
Q54232437 | Nucleobases and corresponding nucleosides display potent antiviral activities against dengue virus possibly through viral lethal mutagenesis. |
Q37623264 | Occurrence and correlates of symptom persistence following acute dengue fever in Peru. |
Q40256314 | Ogilvie's syndrome in severe dengue |
Q86266160 | Ophthalmic complications of dengue: pathogenesis and prevention |
Q28081774 | Overcoming tumor immune evasion with an unique arbovirus |
Q40132249 | PUBLIC HEALTH. Dengue vaccines at a crossroad |
Q40122173 | Paediatric Dengue Fever diagnosed through parents' epidemiologic report and preventive strategy during the acute phase of infection |
Q38749029 | Paper-based point-of-care testing for diagnosis of dengue infections |
Q89992595 | Paracetamol for dengue fever: no benefit and potential harm? |
Q92011762 | Pathogenesis and Immune Response Caused by Vector-Borne and Other Viral Infections in a Tupaia Model |
Q35221052 | Performance of Simplexa dengue molecular assay compared to conventional and SYBR green RT-PCR for detection of dengue infection in Indonesia. |
Q35103195 | Performance of commercial dengue NS1 ELISA and molecular analysis of NS1 gene of dengue viruses obtained during surveillance in Indonesia |
Q36869547 | Persistent Symptoms of Dengue: Estimates of the Incremental Disease and Economic Burden in Mexico. |
Q40037926 | Persistent detection of dengue virus RNA in vaginal secretion of a woman returning from Sri Lanka to Italy, April 2017. |
Q34315171 | Physician survey to determine how dengue is diagnosed, treated and reported in puerto rico |
Q26315462 | Physicians, Primary Caregivers and Topical Repellent: All Under-Utilised Resources in Stopping Dengue Virus Transmission in Affected Households |
Q35043739 | Platelet activating factor contributes to vascular leak in acute dengue infection |
Q26739670 | Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases |
Q36455785 | Postmortem Diagnosis of Dengue as an Epidemiological Surveillance Tool |
Q55338916 | Potent Neutralization Ability of a Human Monoclonal Antibody Against Serotype 1 Dengue Virus. |
Q33431047 | Potential Harm of Prophylactic Platelet Transfusion in Adult Dengue Patients. |
Q50751621 | Predicting ectotherm disease vector spread--benefits from multidisciplinary approaches and directions forward. |
Q30836365 | Predicting local dengue transmission in Guangzhou, China, through the influence of imported cases, mosquito density and climate variability |
Q21146686 | Predicting outcome from dengue |
Q31065710 | Prediction of Dengue Outbreaks Based on Disease Surveillance and Meteorological Data |
Q35109205 | Predictive value of proteinuria in adult dengue severity |
Q89840907 | Preparing for the dengue explosion in Kathmandu, Nepal |
Q56000903 | Prevalence of chronic comorbidities in dengue fever and West Nile virus: A systematic review and meta-analysis |
Q38368332 | Prevention and Control Strategies to Counter Dengue Virus Infection |
Q28729782 | Prevention and control of dengue-the light at the end of the tunnel |
Q40037808 | Prior Exposure to Zika Virus Significantly Enhances Peak Dengue-2 Viremia in Rhesus Macaques |
Q61447814 | Probability of dengue transmission and propagation in a non-endemic temperate area: conceptual model and decision risk levels for early alert, prevention and control |
Q90713910 | Production of tetravalent dengue virus envelope protein domain III based antigens in lettuce chloroplasts and immunologic analysis for future oral vaccine development |
Q40183703 | Profiling of esterified fatty acids as biomarkers in the blood of dengue fever patients using a microliter-scale extraction followed by gas chromatography and mass spectrometry. |
Q58108919 | Prognostic Factors in Adult Patients with Dengue: Developing Risk Scoring Models and Emphasizing Factors Associated with Death ≤7 Days after Illness Onset and ≤3 Days after Presentation |
Q40037516 | Progress and Challenges Towards Point-of-Care Diagnostic Development for Dengue. |
Q56475810 | Projected costs associated with school-based screening to inform deployment of Dengvaxia: Vietnam as a case study |
Q28954574 | Prophylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: a multicentre, open-label, randomised, superiority trial |
Q40040540 | Prospective study of patients with persistent symptoms of dengue in Brazil |
Q26314423 | Prospects for dengue vaccines for travelers |
Q33414156 | Protection against dengue virus infection in mice by administration of antibodies against modified nonstructural protein 1. |
Q29616259 | Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial |
Q34639275 | Proteomic biomarkers for ageing the mosquito Aedes aegypti to determine risk of pathogen transmission |
Q30203504 | Prototype early warning systems for vector-borne diseases in Europe |
Q90040456 | Pulmonary manifestations of dengue |
Q24278786 | Quantifying the Epidemiological Impact of Vector Control on Dengue |
Q59245626 | RNA helicase A is an important host factor involved in dengue virus replication |
Q37670700 | RNA structures that resist degradation by Xrn1 produce a pathogenic Dengue virus RNA |
Q40051947 | Rapid Evolution of Ovarian-Biased Genes in the Yellow Fever Mosquito (Aedes aegypti). |
Q35120222 | Rapid diagnostic tests for dengue virus infection in febrile Cambodian children: diagnostic accuracy and incorporation into diagnostic algorithms. |
Q36992653 | Re-evaluation of the pathogenic roles of nonstructural protein 1 and its antibodies during dengue virus infection |
Q92048656 | Recent transmission of dengue virus and associated risk Facors among residents of Kassala state, eastern Sudan |
Q34093421 | Recognition of heparan sulfate by clinical strains of dengue virus serotype 1 using recombinant subviral particles |
Q38975850 | Recommendations for the management of severe malaria and severe dengue in resource-limited settings |
Q37109553 | Reduced risk of disease during postsecondary dengue virus infections |
Q34374905 | Refining the global spatial limits of dengue virus transmission by evidence-based consensus |
Q26771329 | Relevance of Non-communicable Comorbidities for the Development of the Severe Forms of Dengue: A Systematic Literature Review |
Q38974932 | Repurposing of prochlorperazine for use against dengue virus infection |
Q33429652 | Retracted: Serological and Entomological Study of Dengue in Dang and Chitwan Districts of Nepal |
Q40082112 | Rise and fall of vector infectivity during sequential strain displacements by mosquito-borne dengue virus. |
Q24261424 | Risk analysis for dengue suitability in Africa using the ArcGIS predictive analysis tools (PA tools) |
Q39183973 | Risk assessment of dengue fever in Zhongshan, China: a time-series regression tree analysis. |
Q35053872 | Risk factors for fatality among confirmed adult dengue inpatients in Singapore: a matched case-control study |
Q33997466 | Risk of dengue for tourists and teams during the World Cup 2014 in Brazil |
Q36181531 | Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults |
Q27927999 | Role of Aedes aegypti (Linnaeus) and Aedes albopictus (Skuse) in local dengue epidemics in Taiwan |
Q27003964 | Role of cytochrome P450s in insecticide resistance: impact on the control of mosquito-borne diseases and use of insecticides on Earth |
Q42730574 | Roles of Interferons in Pregnant Women with Dengue Infection: Protective or Dangerous Factors. |
Q88600737 | SELECTED EPIDEMICS & EMERGING PATHOGENS |
Q26700096 | Safety Overview of a Recombinant Live-Attenuated Tetravalent Dengue Vaccine: Pooled Analysis of Data from 18 Clinical Trials |
Q33439772 | Safety and Efficacy of a Single Dose of Anti-D (WinRho®) in Severe Thrombocytopenia Secondary to Dengue Virus Infection |
Q39468688 | Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study |
Q29197289 | Safety and immunogenicity of one versus two doses of Takeda's tetravalent dengue vaccine in children in Asia and Latin America: interim results from a phase 2, randomised, placebo-controlled study. |
Q40235135 | Safety and immunogenicity of three tetravalent dengue vaccine formulations in healthy adults in the USA. |
Q58787712 | Salivary Detection of Dengue Virus NS1 Protein with a Label-Free Immunosensor for Early Dengue Diagnosis |
Q35640994 | Scanning mutagenesis studies reveal a potential intramolecular interaction within the C-terminal half of dengue virus NS2A involved in viral RNA replication and virus assembly and secretion |
Q39470840 | Secretion of dengue virus envelope protein ectodomain from mammalian cells is dependent on domain II serotype and affects the immune response upon DNA vaccination |
Q37660743 | Secretory phospholipase A2 in the pathogenesis of acute dengue infection |
Q36021379 | Sensitivity of the Dengue Surveillance System in Brazil for Detecting Hospitalized Cases |
Q38334130 | Sensorineural hearing loss in hemorrhagic dengue? |
Q66678780 | Serological inference of past primary and secondary dengue infection: implications for vaccination |
Q99635679 | Seropositivity to dengue and associated risk factors among non-malarias acute febrile patients in Arba Minch districts, southern Ethiopia |
Q36876526 | Seroprevalence of acute dengue in a Malaysian tertiary medical centre. |
Q37050534 | Serum Galectin-9 and Galectin-3-Binding Protein in Acute Dengue Virus Infection. |
Q27468816 | Serum Procalcitonin and Peripheral Venous Lactate for Predicting Dengue Shock and/or Organ Failure: A Prospective Observational Study |
Q97549435 | Serum chymase levels correlate with severe dengue warning signs and clinical fluid accumulation in hospitalized pediatric patients |
Q37414121 | Serum metabolomics analysis of patients with chikungunya and dengue mono/co-infections reveals distinct metabolite signatures in the three disease conditions. |
Q90038071 | Severe dengue categories as research endpoints-Results from a prospective observational study in hospitalised dengue patients |
Q33719688 | Severe neutropenia in dengue patients: prevalence and significance |
Q34050264 | Signal propagation in multi-layer DNAzyme cascades using structured chimeric substrates |
Q102075393 | Similarities and differences between the 'cytokine storms' in acute dengue and COVID-19 |
Q35557524 | Site-specific characterization of envelope protein N-glycosylation on Sanofi Pasteur's tetravalent CYD dengue vaccine. |
Q46822697 | Skin dendritic cell and T cell activation associated with dengue shock syndrome |
Q40227094 | Skin rash from dengue fever |
Q36052251 | Slow resolution of inflammation in severe adult dengue patients |
Q56881264 | Spectrum of activity testing for therapeutics against all four dengue virus serotypes in AG129 mouse models: Proof-of-concept studies with the adenosine nucleoside inhibitor NITD-008 |
Q38773323 | Status of vaccine research and development of vaccines for dengue |
Q38045106 | Structural biology of dengue virus enzymes: towards rational design of therapeutics |
Q37145822 | Subacute bilateral vision loss resulting from dengue maculopathy |
Q33414560 | Subversion of early innate antiviral responses during antibody-dependent enhancement of Dengue virus infection induces severe disease in immunocompetent mice |
Q34990697 | Suppression of virus specific immune responses by IL-10 in acute dengue infection |
Q37713941 | Surfactant-modified nanoclay exhibits an antiviral activity with high potency and broad spectrum |
Q40204994 | Survival of larvivorous fish used for biological control of Aedes aegypti (Diptera: Culicidae) combined with different larvicides |
Q92909202 | Systematic review of dengue vaccine efficacy |
Q90461580 | TIM-1 As a Signal Receptor Triggers Dengue Virus-Induced Autophagy |
Q24288867 | Tackling dengue fever: Current status and challenges |
Q37611829 | Targeting host factors to treat West Nile and dengue viral infections |
Q91901533 | Teaching Pediatric Life Support in Limited-Resource Settings: Contextualized Management Guidelines |
Q28533629 | Temephos resistance in Aedes aegypti in Colombia compromises dengue vector control |
Q33681310 | Temperature-dependent folding allows stable dimerization of secretory and virus-associated E proteins of Dengue and Zika viruses in mammalian cells |
Q34535311 | Temporal dynamics of the transcriptional response to dengue virus infection in Nicaraguan children |
Q33747338 | The Antibody-Secreting Cell Response to Infection: Kinetics and Clinical Applications |
Q28954726 | The Complement System in Flavivirus Infections |
Q36206719 | The Dengue Vaccine Dilemma: Balancing the Individual and Population Risks and Benefits. |
Q59360089 | The Development of Peptide-based Antimicrobial Agents against Dengue Virus |
Q28657506 | The Emerging Zika Virus Threat: A Guide for Dermatologists |
Q57146464 | The Estimates of the Health and Economic Burden of Dengue in Vietnam |
Q63740761 | The First Outbreak of Dengue Fever in Greater Darfur, Western Sudan |
Q35858397 | The Hidden Burden of Dengue and Chikungunya in Chennai, India |
Q35877565 | The Molecular Engineering of an Anti-Idiotypic Antibody for Pharmacokinetic Analysis of a Fully Human Anti-Infective |
Q89805021 | The Mosquito Larvicidal Activity of Essential Oils from Cymbopogon and Eucalyptus Species in Vietnam |
Q63246434 | The Organization, Implementation, and Functioning of Dengue Surveillance in India-A Systematic Scoping Review |
Q54257287 | The Tolerability and Efficacy of Oral Isotonic Solution versus Plain Water in Dengue Patients: A Randomized Clinical Trial. |
Q35594746 | The burden of dengue and chikungunya worldwide: implications for the southern United States and California |
Q34006711 | The changing incidence of dengue haemorrhagic fever in Indonesia: a 45-year registry-based analysis |
Q36978907 | The cytokine response of U937-derived macrophages infected through antibody-dependent enhancement of dengue virus disrupts cell apical-junction complexes and increases vascular permeability |
Q35340980 | The deadly ebola threat in the midst of an overwhelming dengue epidemic |
Q40249733 | The expansion of vector-borne diseases and the implications for blood transfusion safety: The case of West Nile Virus, dengue and chikungunya |
Q37547030 | The exploration of risk factors of concurrent bacteraemia in patients critically ill with severe dengue |
Q52345950 | The expression profile of human peripheral blood mononuclear cell miRNA is altered by antibody-dependent enhancement of infection with dengue virus serotype 3. |
Q28388682 | The global burden of dengue: an analysis from the Global Burden of Disease Study 2013 |
Q33945536 | The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases |
Q24628768 | The global distribution and burden of dengue |
Q22680660 | The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus |
Q34522607 | The global economic burden of dengue: a systematic analysis |
Q56000961 | The impact of the age of first blood meal and Zika virus infection on Aedes aegypti egg production and longevity |
Q38772810 | The in vitro and in vivo antiviral properties of combined monoterpene alcohols against West Nile virus infection. |
Q56378131 | The role of lipids in the inception, maintenance and complications of dengue virus infection |
Q35496004 | The role of pre-existing cross-reactive antibodies in determining the efficacy of vaccination in humans: study protocol for a randomized controlled trial |
Q35849296 | The use of rapid dengue diagnostic tests in a routine clinical setting in a dengue-endemic area of Colombia |
Q33441421 | The value of daily platelet counts for predicting dengue shock syndrome: Results from a prospective observational study of 2301 Vietnamese children with dengue |
Q38149195 | Therapeutic antibodies as a treatment option for dengue fever |
Q34431491 | Therapeutics for dengue: recommendations for design and conduct of early-phase clinical trials |
Q33423030 | Thrombocytopenia in Dengue: Interrelationship between Virus and the Imbalance between Coagulation and Fibrinolysis and Inflammatory Mediators |
Q28954686 | Time to stop prophylactic platelet transfusion for adult dengue |
Q33854218 | Time-varying, serotype-specific force of infection of dengue virus |
Q36112987 | Total and Envelope Protein-Specific Antibody-Secreting Cell Response in Pediatric Dengue Is Highly Modulated by Age and Subsequent Infections |
Q89495203 | Transient Expression of Dengue Virus NS1 Antigen in Nicotiana benthamiana for Use as a Diagnostic Antigen |
Q36444531 | Trends in Dengue Cases Imported into the United States from Pan America 2001-2012 |
Q28074355 | Trends in clinical trials of dengue vaccine |
Q30145525 | Trends of Dengue Disease Epidemiology |
Q26829882 | Two cases of false-positive dengue non-structural protein 1 (NS1) antigen in patients with hematological malignancies and a review of the literature on the use of NS1 for the detection of Dengue infection |
Q40033679 | Two disciplines, one priority: the seamless integration of human and veterinary microbiology is urgent |
Q33744074 | Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines |
Q54226258 | Understanding dengue virus evolution to support epidemic surveillance and counter-measure development. |
Q38288358 | Unusual Presentation of Dengue Fever: A child with acute myocarditis. |
Q40218361 | Unusual and rare manifestations of dengue during a dengue outbreak in a tertiary care hospital in South India |
Q35072070 | Unusual presentation of chikungunya virus infection with concomintant erysipelas in a returning traveler from the Caribbean: a case report |
Q92839467 | Upregulation of SCUBE1 in Dengue Virus Infection |
Q33884602 | Urban Chikungunya in the Middle East and North Africa: A systematic review |
Q38126179 | Urbanization and geographic expansion of zoonotic arboviral diseases: mechanisms and potential strategies for prevention |
Q36157629 | Use of Warning Signs for Dengue by Pediatric Health Care Staff in Brazil |
Q34600668 | Use of expansion factors to estimate the burden of dengue in Southeast Asia: a systematic analysis |
Q33418844 | Use of simple clinical and laboratory predictors to differentiate influenza from dengue and other febrile illnesses in the emergency room |
Q40277788 | Use of the tourniquet test in diagnosing dengue-like syndrome |
Q56417600 | Using paired serology and surveillance data to quantify dengue transmission and control during a large outbreak in Fiji |
Q35889724 | Utility of C-Reactive Protein Levels for Early Prediction of Dengue Severity in Adults |
Q42355484 | VERTICAL TRANSMISSION OF DENGUE INFECTION: THE FIRST PUTATIVE CASE REPORTED IN CHINA. |
Q104692319 | Vaccination coverage and adherence to a dengue vaccination program in the state of Paraná, Brazil |
Q24288750 | Value of Routine Dengue Diagnostic Tests in Urine and Saliva Specimens |
Q39409129 | Vascular leakage in dengue--clinical spectrum and influence of parenteral fluid therapy |
Q99565737 | Vector-borne diseases in pregnancy |
Q28080121 | Viral arthritis |
Q36082908 | Viral kinetics of primary dengue virus infection in non-human primates: a systematic review and individual pooled analysis |
Q34722636 | Worldwide spread of Dengue virus type 1. |
Q58276963 | Zika Virus |
Q33433912 | Zika Virus Infection Associated With Severe Thrombocytopenia |
Q43046770 | Zika virus (ZIKV) Replication is Substantially Inhibited by Novel Favipiravir and Interferon-alpha Combination Regimens |
Q90040682 | Zika virus infection in the genital tract of non-pregnant females: a systematic review |
Q38156532 | Zika, Chikungunya, and Other Emerging Vector-Borne Viral Diseases |
Q40142502 | microRNA expression in blood of dengue patients |
Search more.